Markets finish week down after bouncing on Bannon's exit >>> READ MORE

Big Pharma: 2012-13’s Flu Vaccine Field

A look at the players that could see a bump this flu season

      View All  


U.K.-based GlaxoSmithKline (NYSE:GSK) is the manufacturer of the Fluarix vaccine (for ages 3 and up), as well as FluLaval.

Don’t get confused about the flu vaccine’s maker here. A company called ID Biomedical manufactures FluLaval, but that’s a subsidiary of Glaxo’s thanks to a 2006 acquisition.

Some experts predict $375 million worth of FluLaval sales this year, though again — not a big chunk considering GSK’s $27 billion in annual revenues.

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC